Original Research
Accepted on 16 May 2025
Trifolin inhibits the calcium-driven contraction pathway in vascular smooth muscle
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1573483
Type at least 3 characters
1,299 articles
Review
Published on 16 May 2025
Global research trends and hotspots in aspirin studies (2014–2024): a bibliometric perspective
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1513318
- 138 views
Review
Published on 15 May 2025
Investigation of the mechanism of hypertension caused by BTKi in the treatment of hematologic diseases
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1585061
- 249 views
Editorial
Published on 15 May 2025
Editorial: Emerging trends in cardiac and skeletal muscle pharmacotherapy
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1619972
- 111 views
Review
Accepted on 14 May 2025
Advances in the treatment of lower-extremity ischemia-reperfusion injury
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1576091
Original Research
Accepted on 14 May 2025
Adenosine deaminase mediates endothelial inflammation via an ADA1-CD26 interaction in post-COVID
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578973
Original Research
Accepted on 14 May 2025
Revealing the mechanisms of warfarin-induced vascular calcification through metabolomics and network toxicology
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1554987
Mini Review
Published on 14 May 2025
The role of statins in the regulation of breast and colorectal cancer and future directions
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578345
- 247 views
Review
Published on 12 May 2025
Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1510275
- 254 views
Mini Review
Published on 08 May 2025
Cardiovascular toxicities associated with chimeric antigen receptor T-cell therapy
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1578157
- 459 views
Review
Accepted on 05 May 2025
Decoding Glycosylation in Cardiovascular Diseases: Mechanisms, Biomarkers, and Therapeutic Opportunities
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1570158
Original Research
Accepted on 30 Apr 2025
Cardiovascular effects of 6-nitrodopamine, adrenaline, noradrenaline, and dopamine in normotensive and hypertensive rats
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1557997
- 144 views
Original Research
Published on 30 Apr 2025
Pulmonary artery-targeted low-dose metformin-loaded nanocapsules safely improve pulmonary arterial hypertension in rats
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1577570
- 611 views
Review
Published on 30 Apr 2025
Macrophage-driven exosomes regulate the progression of cardiovascular disease
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563800
- 584 views
Original Research
Accepted on 29 Apr 2025
Trapidil Attenuates Diabetic Cardiomyopathy via GPX3/Nrf2-Mediated Inhibition of Myocardial Pyroptosis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566622
- 113 views
Review
Accepted on 29 Apr 2025
Metalloproteinases (MMPs) in Hypertensive Disorders: Role, Function, Pharmacology, and Potential Strategies to Mitigate Pathophysiological Changes
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559288
- 120 views